SCHEMBL21783403

SCHEMBL21783403

COc1ccc(CN(Sc2cc(C)c(F)cn2)c2ccsn2)cc1

nearest known ligand 0.32

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
QPCT Q16769 2/20 0.32
APLNR P35414 2/20 0.32
SCN1A P35498 1/20 0.32
SCN2A Q99250 1/20 0.32
SCN3A Q9NY46 1/20 0.32
ALDH1A1 P00352 2/20 0.31
POLB P06746 1/20 0.31
LMNA P02545 2/20 0.30
MEN1 O00255 1/20 0.30
CYP1A2 P05177 1/20 0.30
CHRM2 P08172 1/20 0.30
CYP3A4 P08684 1/20 0.30
HTR1A P08908 1/20 0.30
ADRA2A P08913 1/20 0.30
CYP2D6 P10635 1/20 0.30
TSHR P16473 1/20 0.30
DRD1 P21728 1/20 0.30
HTR2A P28223 1/20 0.30
HTR2C P28335 1/20 0.30
SLC6A4 P31645 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21773265 0.77 CNR2 (0.41) APLNRALDH1A1LMNA
SCHEMBL21794109 0.72 ALDH1A1 (0.34) APLNRALDH1A1POLBLMNAMEN1
SCHEMBL21783377 0.69 MEN1 (0.37) APLNRALDH1A1LMNAMEN1CYP1A2
SCHEMBL21783387 0.68 SSTR4 (0.30)
SCHEMBL21783460 0.66 ALDH1A1 (0.34) APLNRALDH1A1POLBLMNAMEN1
Hydrogen Sulfide SCHEMBL21783528 0.65 APLNR (0.31) QPCTAPLNRSCN1ASCN2ASCN3A
SCHEMBL21794068 0.65 APLNR (0.34) APLNRALDH1A1LMNAMEN1CYP1A2
SCHEMBL19634161 0.62 ALDH1A1 (0.34) QPCTAPLNRSCN1ASCN2ASCN3A
SCHEMBL19634304 0.61 ACLY (0.35) QPCTAPLNRSCN1AALDH1A1LMNA
SCHEMBL19634192 0.61 APLNR (0.34) QPCTAPLNRALDH1A1LMNAMEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2020047323-A1 HETEROARYL-SUBSTITUTED SULFONAMIDE COMPOUNDS AND THEIR USE AS THERAPEUTIC AGENTS XENON PHARMACEUTICALS INC. (CA) 2020-03-05 WO disclosed
WO-2020047312-A1 HETEROARYL-SUBSTITUTED SULFONAMIDE COMPOUNDS AND THEIR USE AS SODIUM CHANNEL INHIBITORS XENON PHARMACEUTICALS INC. (CA) 2020-03-05 WO disclosed